NPI: 1972628006 · ELKHORN, WI 53121 · General Acute Care Hospital · NPI assigned 03/20/2007
Authorized official RICHARDSON, KARA controls 20+ related entities in our dataset. Read more
| Authorized Official | RICHARDSON, KARA (VP MANAGED HEALTH) |
| NPI Enumeration Date | 03/20/2007 |
Other providers sharing the same authorized official: RICHARDSON, KARA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 36,950 | $947K |
| 2019 | 35,154 | $925K |
| 2020 | 32,586 | $849K |
| 2021 | 44,985 | $1.04M |
| 2022 | 46,492 | $1.07M |
| 2023 | 52,530 | $1.25M |
| 2024 | 39,179 | $1.03M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 26,364 | 8,434 | $891K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 12,351 | 11,143 | $772K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,687 | 4,014 | $670K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 10,873 | 9,654 | $598K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7,032 | 6,182 | $389K |
| 80053 | Comprehensive metabolic panel | 14,066 | 11,480 | $296K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 13,370 | 4,836 | $284K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,527 | 3,229 | $230K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,708 | 2,495 | $207K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,863 | 2,611 | $193K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 7,428 | 4,303 | $183K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,721 | 1,482 | $174K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3,080 | 2,678 | $171K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 16,387 | 12,834 | $106K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2,630 | 2,440 | $105K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,525 | 1,020 | $90K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,164 | 1,949 | $90K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 900 | 836 | $89K |
| 97161 | 2,043 | 1,961 | $88K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 3,567 | 1,596 | $82K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,795 | 1,145 | $79K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 776 | 704 | $61K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 874 | 733 | $56K |
| 97162 | 1,607 | 1,521 | $55K | |
| 82077 | 2,013 | 1,703 | $55K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,693 | 2,072 | $51K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 732 | 669 | $51K |
| 84484 | 4,788 | 4,090 | $51K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 948 | 792 | $50K |
| 81025 | 4,373 | 3,881 | $42K | |
| 76801 | 806 | 685 | $41K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,043 | 2,771 | $36K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 144 | 130 | $35K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 866 | 830 | $34K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 754 | 691 | $33K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 367 | 339 | $32K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 273 | 255 | $30K |
| 83735 | 5,689 | 4,397 | $28K | |
| 83880 | 873 | 772 | $27K | |
| 76830 | Ultrasound, transvaginal | 701 | 650 | $26K |
| 83690 | 4,234 | 3,604 | $25K | |
| 83605 | 2,793 | 2,421 | $25K | |
| 84145 | 1,195 | 1,077 | $22K | |
| 81001 | 5,284 | 4,752 | $21K | |
| 82962 | 2,616 | 1,478 | $20K | |
| G0378 | Hospital observation service, per hour | 1,064 | 921 | $18K |
| 93356 | 190 | 177 | $18K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 233 | 212 | $17K |
| 81003 | 2,893 | 2,603 | $17K | |
| 80143 | 1,319 | 1,143 | $16K | |
| 80179 | 1,304 | 1,137 | $16K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 392 | 367 | $16K |
| 97035 | 1,292 | 556 | $16K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 57 | 52 | $16K |
| 93975 | 427 | 391 | $15K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1,133 | 1,032 | $14K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 409 | 393 | $13K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 188 | 171 | $13K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 208 | 197 | $12K |
| 87040 | 1,017 | 853 | $12K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5,019 | 4,073 | $12K |
| 72125 | Computed tomography, cervical spine; without contrast material | 447 | 411 | $12K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 222 | 104 | $11K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 166 | 146 | $11K |
| 85379 | 1,408 | 1,290 | $11K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 31 | 30 | $10K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 107 | 64 | $10K |
| 97535 | Self-care/home management training, each 15 minutes | 804 | 558 | $9K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 89 | 82 | $9K |
| 85610 | 2,559 | 2,213 | $8K | |
| 71046 | Radiologic examination, chest; 2 views | 1,730 | 1,641 | $8K |
| 87081 | 222 | 205 | $7K | |
| 85730 | 1,389 | 1,260 | $6K | |
| 71250 | 193 | 173 | $5K | |
| 87077 | 357 | 328 | $5K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 7,797 | 6,721 | $4K |
| 86850 | 256 | 230 | $4K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 38 | 37 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 260 | 243 | $4K |
| 86900 | 418 | 374 | $4K | |
| 87186 | 395 | 363 | $3K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 66 | 64 | $3K |
| 71045 | Radiologic examination, chest; single view | 4,527 | 4,069 | $2K |
| 97116 | 173 | 82 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 216 | 183 | $2K |
| 0240U | 65 | 62 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,643 | 1,619 | $2K |
| 93971 | 30 | 28 | $1K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 325 | 250 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 38 | 38 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 38 | 38 | $1K |
| 82565 | 90 | 85 | $1K | |
| 84112 | 15 | 12 | $1K | |
| 97597 | 38 | 25 | $1K | |
| 97165 | 30 | 30 | $1K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 21 | 19 | $1K |
| 86901 | 418 | 374 | $1K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 103 | 84 | $919.96 |
| 85027 | 103 | 93 | $909.17 | |
| 84702 | 28 | 25 | $829.44 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,014 | 3,292 | $670.88 |
| 93017 | 14 | 13 | $471.39 | |
| 0399T | 16 | 13 | $441.57 | |
| 73630 | 107 | 98 | $423.44 | |
| 82550 | 82 | 68 | $416.30 | |
| 87088 | 54 | 48 | $364.52 | |
| 86140 | 100 | 78 | $344.28 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 15 | 12 | $307.86 |
| 94060 | 13 | 12 | $296.60 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 85 | 70 | $231.61 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,878 | 3,159 | $177.38 |
| 87807 | 17 | 13 | $151.80 | |
| 85652 | 62 | 52 | $132.02 | |
| 87210 | 14 | 14 | $72.60 | |
| 73030 | 27 | 24 | $63.21 | |
| 73610 | 44 | 41 | $56.15 | |
| 73562 | 13 | 13 | $47.99 | |
| 73130 | 15 | 14 | $37.74 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 8,448 | 6,462 | $17.43 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 495 | 458 | $17.27 |
| 74018 | 15 | 12 | $16.00 | |
| 96376 | 750 | 537 | $14.36 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,770 | 1,204 | $6.51 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 29 | 26 | $4.32 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 4,798 | 3,779 | $3.07 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 5,006 | 4,288 | $2.80 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,118 | 949 | $2.78 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 396 | 337 | $2.69 |
| 36415 | Collection of venous blood by venipuncture | 1,583 | 1,088 | $2.64 |
| J2060 | Injection, lorazepam, 2 mg | 553 | 409 | $0.74 |
| J2704 | Injection, propofol, 10 mg | 3,272 | 2,433 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 288 | 244 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 1,052 | 946 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,330 | 2,074 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,939 | 1,723 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1,421 | 1,130 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 513 | 334 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 877 | 715 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 40 | 12 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 148 | 99 | $0.00 |
| 80320 | 51 | 42 | $0.00 | |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 13 | 12 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 93 | 84 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 4,780 | 3,947 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 1,089 | 940 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 314 | 256 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 163 | 146 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,098 | 806 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 241 | 210 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 27 | 25 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 25 | 12 | $0.00 |
| 94726 | 13 | 12 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 22 | 12 | $0.00 |
| 94729 | 13 | 12 | $0.00 |